The content is available as a PDF (177.2 KB).
. 2022 Jul 4;77:S307. doi: 10.1016/S0168-8278(22)00981-3
Cholangiopathy after severe COVID-19: what do we know so far?
Valéria Ferreira de Almeida e Borges
, Helma Pinchemel Cotrim
, Marcelo Simão Ferreira
, José Humberto Caetano Marins
, Haroldo Luis Oliva Gomes Rocha
, Leonardo Augusto Dias Nascimento
, Mayra Machado Fleury Guedes
, Julia Esteves Guerra
Valéria Ferreira de Almeida e Borges
Find articles by Valéria Ferreira de Almeida e Borges
Helma Pinchemel Cotrim
Find articles by Helma Pinchemel Cotrim
Marcelo Simão Ferreira
Find articles by Marcelo Simão Ferreira
José Humberto Caetano Marins
Find articles by José Humberto Caetano Marins
Haroldo Luis Oliva Gomes Rocha
Find articles by Haroldo Luis Oliva Gomes Rocha
Leonardo Augusto Dias Nascimento
Find articles by Leonardo Augusto Dias Nascimento
Mayra Machado Fleury Guedes
Find articles by Mayra Machado Fleury Guedes
Julia Esteves Guerra
Find articles by Julia Esteves Guerra
Issue date 2022 Jul.
Copyright © 2022 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC9252391